Chris D. Kazmierczak

Chris Kazmierczak practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Chris Kazmierczak's NPI, 1932169794, was assigned on March 24, 2006. Chris Kazmierczak graduated from Wayne State University School Of Medicine in 1992. Chris Kazmierczak holds Michigan license 4301059588.

Chris Kazmierczak's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Chris Kazmierczak's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Chris Kazmierczak is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Medical Education Associates. Dmand AI also links Chris Kazmierczak to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Chris Kazmierczak practices, 4 sites in all. Vendor and product names are available with a free account.

Neuroradiology is Chris Kazmierczak's primary specialty in the NPI Registry, under taxonomy code 2085N0700X. Chris Kazmierczak is board certified in diagnostic radiology by the American Board of Radiology. Chris Kazmierczak is licensed in Michigan.

CMS data shows 212 Medicare services from Chris Kazmierczak across 8 procedure codes in 2024, for 243 Medicare patients. Medicare paid $15,131 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 243 Medicare patients who saw Chris Kazmierczak in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Chris Kazmierczak's median patient age at 65, with 66% women.

In 2024, Chris Kazmierczak wrote 52 Medicare Part D claims for 20 patients. CMS names the drug for 43 of them, across 2 drugs with 11 or more claims each, at $18,321 in total drug cost. In 2023, CMS named 26 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Chris Kazmierczak for performance year 2024, reported as part of a group. Chris Kazmierczak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Chris Kazmierczak as offering telehealth.

Dmand AI links 8 papers to Chris Kazmierczak, published from 2011 to 2022. The most frequent topics are Carotid Stenosis, Endarterectomy, Carotid and Magnetic Resonance Imaging. Chris Kazmierczak's most frequent co-authors are Neeraj Chaudhary, MD, Joseph John Gemmete, MD and Byron G. Thompson, MD.

CMS Open Payments shows 3 general payments to Chris Kazmierczak from 2 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. MicroVention, Inc. paid the most, $131.

Chris Kazmierczak graduated from Wayne State University School Of Medicine in 1992.

Chris Kazmierczak is in network with 8 carriers, including Health Alliance Plan, Priority Health and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.